How to Cite this Article: Zadeh N, Bernstein J, Niemi AK, Dugan S, Kwan A, Liang D, Hyland JC, Hoyme HE, Hudgins L, Manning MA. 2011. Ectopia lentis as the presenting and primary feature in Marfan syndrome. Am J Med Genet Part A 155: 2661–2668.
Ectopia lentis as the presenting and primary feature in Marfan syndrome†
Article first published online: 19 SEP 2011
Copyright © 2011 Wiley Periodicals, Inc.
American Journal of Medical Genetics Part A
Volume 155, Issue 11, pages 2661–2668, November 2011
How to Cite
Zadeh, N., Bernstein, J. A., Niemi, A. K., Dugan, S., Kwan, A., Liang, D., Hyland, J. C., Hoyme, H. E., Hudgins, L. and Manning, M. A. (2011), Ectopia lentis as the presenting and primary feature in Marfan syndrome. Am. J. Med. Genet., 155: 2661–2668. doi: 10.1002/ajmg.a.34245
- Issue published online: 20 OCT 2011
- Article first published online: 19 SEP 2011
- Manuscript Accepted: 14 JUL 2011
- Manuscript Received: 28 OCT 2010
- ectopia lentis;
- marfan syndrome;
- aortic root dilatation;
- cardiac surveillance;
- ghent criteria
Marfan syndrome (MFS) is a multisystem connective tissue disorder with primary involvement of the ocular, cardiovascular, and skeletal systems. We report on eight patients, all presenting initially with bilateral ectopia lentis (EL) during early childhood. These individuals did not have systemic manifestations of MFS, and did not fulfill the revised Ghent diagnostic criteria. However, all patients had demonstratable, disease-causing missense mutations in the FBN1 gene. Based on molecular results, cardiovascular imaging was recommended and led to the identification of mild aortic root changes in seven of the eight patients. The remaining patient had mitral valve prolapse with a normal appearing thoracic aorta. The findings presented in this paper validate the necessity of FBN1 gene testing in all individuals presenting with isolated EL. As we observed, these individuals are at increased risk of cardiovascular complications. Furthermore, we also noted that the majority of our patient cohort's mutations occurred in the 5′ portion of the FBN1 gene, and were found to affect highly conserved cysteine residues, which may indicate a possible genotype–phenotype correlation. We conclude that in patients with isolated features of EL, FBN1 mutation analysis is necessary to aid in providing prompt diagnosis, and to identify patients at risk for potentially life-threatening complications. Additionally, knowledge of the type and location of an FBN1 mutation may be useful in providing further clinical correlation regarding phenotypic progression and appropriate medical management. © 2011 Wiley Periodicals, Inc.